| Form type | Sec Links | Description | Filing date | Reporting date |
|---|---|---|---|---|
| 10-Q | Report | Data | 10-Q | Nov 6, 2024 | Sep 30, 2024 |
| 8-K | Report | Data | FORM 8-K | Nov 6, 2024 | Nov 6, 2024 |
| SC 13G | Report | Sep 12, 2024 | ||
| 8-K | Report | Data | 8-K | Sep 5, 2024 | Sep 3, 2024 |
| 8-K | Report | Data | 8-K | Aug 19, 2024 | Aug 14, 2024 |
| 8-K | Report | Data | 8-K | Aug 8, 2024 | Aug 7, 2024 |
| 10-Q | Report | Data | 10-Q | Aug 6, 2024 | Jun 30, 2024 |
| 8-K | Report | Data | FORM 8-K | Aug 6, 2024 | Aug 6, 2024 |
| 8-K | Report | Data | 8-K | Jun 28, 2024 | Jun 27, 2024 |
| 8-K | Report | Data | 8-K | May 31, 2024 | May 29, 2024 |
| 8-K | Report | Data | 8-K | May 22, 2024 | May 21, 2024 |
| 8-K | Report | Data | 8-K | May 15, 2024 | May 9, 2024 |
| 10-Q | Report | Data | 10-Q | May 7, 2024 | Mar 31, 2024 |
| 8-K | Report | Data | FORM 8-K | May 7, 2024 | May 7, 2024 |
| 10-K | Report | Data | 10-K | Mar 12, 2024 | Dec 31, 2023 |
| 8-K | Report | Data | FORM 8-K | Mar 12, 2024 | Mar 12, 2024 |
| 8-K | Report | Data | 8-K | Feb 28, 2024 | Feb 27, 2024 |
| SC 13G/A | Report | Feb 14, 2024 | ||
| SC 13G/A | Report | ALIGOS THERAPEUTICS, INC. | Feb 14, 2024 | |
| SC 13G/A | Report | SC 13G/A | Feb 14, 2024 | |
| SC 13G/A | Report | AMENDMENT NO. 2 | Feb 14, 2024 | |
| SC 13G | Report | Feb 14, 2024 | ||
| SC 13G | Report | Feb 14, 2024 | ||
| SC 13D/A | Report | SC 13D/A | Feb 8, 2024 | |
| 8-K | Report | Data | 8-K | Jan 25, 2024 | Jan 25, 2024 |
| 8-K | Report | Data | 8-K | Nov 22, 2023 | Nov 20, 2023 |
| 8-K | Report | Data | 8-K | Nov 15, 2023 | Nov 9, 2023 |
| SC 13G/A | Report | SC 13G/A | Nov 7, 2023 | |
| SC 13D | Report | SC 13D | Nov 6, 2023 | |
| 10-Q | Report | Data | 10-Q | Nov 2, 2023 | Sep 30, 2023 |
| SC 13G | Report | Nov 2, 2023 | ||
| 8-K | Report | Data | FORM 8-K | Nov 2, 2023 | Nov 2, 2023 |
| 8-K | Report | Data | 8-K | Oct 25, 2023 | Oct 23, 2023 |
| 8-K | Report | Data | 8-K | Oct 18, 2023 | Oct 16, 2023 |
| 8-K | Report | Data | 8-K | Sep 7, 2023 | Sep 5, 2023 |
| 10-Q | Report | Data | 10-Q | Aug 3, 2023 | Jun 30, 2023 |
| 8-K | Report | Data | FORM 8-K | Aug 3, 2023 | Aug 3, 2023 |
| 8-K | Report | Data | 8-K | Aug 1, 2023 | Jul 31, 2023 |
| 8-K | Report | Data | 8-K | Jul 25, 2023 | Jul 20, 2023 |
| 10-Q | Report | Data | 10-Q | May 4, 2023 | Mar 31, 2023 |
| 8-K | Report | Data | FORM 8-K | May 4, 2023 | May 4, 2023 |
| 10-K | Report | Data | 10-K | Mar 9, 2023 | Dec 31, 2022 |
| 8-K | Report | Data | FORM 8-K | Mar 9, 2023 | Mar 9, 2023 |
| SC 13G/A | Report | ALIGOS THERAPEUTICS, INC. | Feb 14, 2023 | |
| SC 13G/A | Report | AMENDMENT NO. 1 | Feb 14, 2023 | |
| SC 13G/A | Report | Feb 13, 2023 | ||
| SC 13G/A | Report | JHG PLC OWNS <5% | Feb 9, 2023 | |
| SC 13G/A | Report | SC 13G/A | Feb 8, 2023 | |
| SC 13G | Report | Dec 27, 2022 | ||
| 10-Q | Report | Data | 10-Q | Nov 2, 2022 | Sep 30, 2022 |
| 8-K | Report | Data | FORM 8-K | Nov 2, 2022 | Nov 2, 2022 |
| 10-Q | Report | Data | 10-Q | Aug 4, 2022 | Jun 30, 2022 |
| 8-K | Report | Data | FORM 8-K | Aug 4, 2022 | Aug 4, 2022 |
| 8-K | Report | Data | 8-K | Jun 27, 2022 | Jun 23, 2022 |
| 10-Q | Report | Data | 10-Q | May 4, 2022 | Mar 31, 2022 |
| 8-K | Report | Data | FORM 8-K | May 4, 2022 | May 4, 2022 |
| 8-K | Report | Data | 8-K | Mar 30, 2022 | Mar 26, 2022 |
| 8-K | Report | Data | 8-K | Mar 22, 2022 | Mar 22, 2022 |
| 10-K | Report | Data | 10-K | Mar 10, 2022 | Dec 31, 2021 |
| 8-K | Report | Data | FORM 8-K | Mar 10, 2022 | Mar 10, 2022 |
| SC 13G | Report | Feb 14, 2022 | ||
| SC 13G/A | Report | Feb 14, 2022 | ||
| SC 13G | Report | SCHEDULE 13G | Feb 14, 2022 | |
| SC 13G/A | Report | ALIGOS THERAPEUTICS, INC. | Feb 14, 2022 | |
| SC 13G | Report | JANUS HENDERSON GROUP PLC OWNS 5.7% OF ALIGOS CIK 0001799448 | Feb 14, 2022 | |
| SC 13G/A | Report | SC 13G/A | Feb 10, 2022 | |
| SC 13G/A | Report | SC 13G/A | Feb 10, 2022 | |
| SC 13G/A | Report | SEC SCHEDULE 13G | Feb 10, 2022 | |
| SC 13G/A | Report | SEC SCHEDULE 13G | Feb 4, 2022 | |
| SC 13G/A | Report | SEC SCHEDULE 13G | Feb 4, 2022 | |
| SC 13D/A | Report | SC 13D/A | Jan 31, 2022 | |
| 8-K | Report | Data | 8-K | Jan 6, 2022 | Jan 6, 2022 |
| 8-K | Report | Data | 8-K | Nov 18, 2021 | Nov 16, 2021 |
| 10-Q | Report | Data | 10-Q | Nov 4, 2021 | Sep 30, 2021 |
| 8-K | Report | Data | FORM 8-K | Nov 4, 2021 | Nov 4, 2021 |
| SC 13G | Report | Aug 13, 2021 | ||
| 10-Q | Report | Data | 10-Q | Aug 5, 2021 | Jun 30, 2021 |
| 8-K | Report | FORM 8-K | Aug 5, 2021 | Aug 5, 2021 |
| 8-K | Report | 8-K | Jun 24, 2021 | Jun 17, 2021 |
| 8-K/A | Report | 8-K/A | Jun 24, 2021 | Apr 26, 2021 |
| SC 13D/A | Report | SC 13D/A | Jun 21, 2021 | |
| SC 13D/A | Report | SC 13D/A | Jun 21, 2021 | |
| 10-Q | Report | Data | 10-Q | May 10, 2021 | Mar 31, 2021 |
| 8-K | Report | FORM 8-K | May 10, 2021 | May 10, 2021 |
| SC 13D/A | Report | SC 13D/A | May 3, 2021 | |
| 8-K | Report | 8-K | Apr 27, 2021 | Apr 26, 2021 |
| 10-K | Report | Data | 10-K | Mar 23, 2021 | Dec 31, 2020 |
| 8-K | Report | FORM 8-K | Mar 23, 2021 | Mar 23, 2021 |
| SC 13G | Report | ALIGOS THERAPEUTICS, INC. | Feb 16, 2021 | |
| SC 13G | Report | SC 13G | Feb 16, 2021 | |
| SC 13G | Report | SC 13G | Feb 11, 2021 | |
| SC 13G | Report | SC 13G | Feb 11, 2021 | |
| SC 13G | Report | SEC SCHEDULE 13G | Jan 11, 2021 | |
| 10-Q | Report | Data | 10-Q | Nov 25, 2020 | Sep 30, 2020 |
| SC 13D | Report | SC 13D | Oct 30, 2020 | |
| SC 13G | Report | SCHEDULE 13G | Oct 28, 2020 | |
| SC 13D | Report | SC 13D | Oct 22, 2020 | |
| SC 13G | Report | SEC SCHEDULE 13G | Oct 22, 2020 | |
| 8-K | Report | 8-K | Oct 20, 2020 | Oct 20, 2020 |